Awarded
Suministro de medicamentos exclusivos epidyolex (cannabidiol)
Original language: Spanish
- Contract value
- €819,936
- Bids received
- 1
- Published
- 14 Apr 2026
- Awarded
- 13 Apr 2026
- Contract start
- 13 Apr 2026
- Contract end
- 1 May 2027estimated
More awards from this buyer
| Awarded | Buyer | Winner | Contract value | Published |
|---|
| Suministro de medicamento exclusivo Blinatumomab 38,5 microgramos inyectable (Blincyto 38,5 mcg) | Hospital Infantil Universitario Niño Jesús | AMGEN, S.A. | €115,385 | 29 Oct 2026 |
| Suministro de medicamento exclusivo Ravulizumab | Hospital Infantil Universitario Niño Jesús | ALEXION PHARMA SPAIN, S.L | €157,771 | 15 Sept 2026 |
| Vosoritida 0,8 mg/ml inyectable | Hospital Infantil Universitario Niño Jesús | BIOMARIN PHARMACEUTICALS ESPAÑA, S.L | €195,578 | 1 Sept 2026 |
| Elosulfasa alfa 1 mg/ml inyectable 5 ml | Hospital Infantil Universitario Niño Jesús | BIOMARIN PHARMACEUTICALS ESPAÑA, S.L | €123,362 | 1 Sept 2026 |
| Cerliponasa alfa 150 mg iny perf vial | Hospital Infantil Universitario Niño Jesús | BIOMARIN PHARMACEUTICALS ESPAÑA, S.L | €457,080 | 1 Sept 2026 |
| Medicamento exclusivo Setmelanotida 10 mg/ml inyectable 1 ml (envase 1 vial) | Hospital Infantil Universitario Niño Jesús | EUROMED PHARMA SPAIN S.L. | €424,819 | 28 Aug 2026 |